Diabetes, Vol 41, Issue 8 998-1008, Copyright © 1992 by American Diabetes Association

ARTICLES

Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD mice

M Nagata and JW Yoon
Laboratory of Viral Immunopathogenesis of Diabetes, Julia McFarlane Diabetes Research Centre, Calgary, Alberta, Canada.

Six CD4+ and three CD8+ islet-reactive T-cell clones were established from lymphocytes infiltrating the pancreatic islets of NOD mice. Two of six CD4+ T-cell clones responded to NOD islet cells only, not to spleen cells. The remaining four clones responded to both islet cells and spleen cells from NOD mice, but not to cells from other strains of mice, including SJL, C3H, C57BL/6, and DBA/2 mice. None of the CD4+ T-cell clones had a cytotoxic effect on the cultured islet cells. On the other hand, all of the CD8+ T-cell clones showed both a proliferative response and a cytotoxic effect on the islet cells, with the restriction of MHC class I H-2Db. Electron microscopic studies revealed that islet-specific CD4+ T-cells attached closely to islet cells but did not destroy them. In contrast, CD8+ T-cell clones showed pseudopodialike protrusions into beta-cells, but not alpha- or delta-cells, leading to selective destruction of beta-cells. CD8+ CTLs could not be isolated from islets of NOD mice less than 10 wk of age, even if the islets showed lymphocytic infiltration, whereas CD4+ T-cells could be isolated from islets of these younger NOD mice. On the basis of these observations, we concluded that CD4+ and CD8+ T-cells interact differently with beta-cells at different stages in T-cell--mediated beta-cell destruction. CD4+ T-cells may secrete cytokines, which in turn activate effector cell populations, whereas CD8+ T-cells may act as a final effector directly involved in beta-cell destruction.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. R. Burton, E. Vincent, P. Y. Arnold, G. P. Lennon, M. Smeltzer, C.-S. Li, K. Haskins, J. Hutton, R. M. Tisch, E. E. Sercarz, et al. On the Pathogenicity of Autoantigen-Specific T-Cell Receptors Diabetes, May 1, 2008; 57(5): 1321 - 1330. [Abstract] [Full Text] [PDF]

				J. S. Haring, L. L. Pewe, and S. Perlman Bystander CD8 T Cell-Mediated Demyelination After Viral Infection of the Central Nervous System J. Immunol., August 1, 2002; 169(3): 1550 - 1555. [Abstract] [Full Text] [PDF]

				M. Bao, Y. Yang, H.-S. Jun, and J.-W. Yoon Molecular Mechanisms for Gender Differences in Susceptibility to T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice J. Immunol., May 15, 2002; 168(10): 5369 - 5375. [Abstract] [Full Text] [PDF]

				M. Poulin and K. Haskins Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse J. Immunol., March 15, 2000; 164(6): 3072 - 3078. [Abstract] [Full Text] [PDF]

				B. Anderson, B.-J. Park, J. Verdaguer, A. Amrani, and P. Santamaria Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes PNAS, August 3, 1999; 96(16): 9311 - 9316. [Abstract] [Full Text] [PDF]

				J. Yoon, C. Yoon, H. Lim, Q. Q. Huang, Y. Kang, K. H. Pyun, K. Hirasawa, R. S. Sherwin, and H. Jun Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in  Cells Science, May 14, 1999; 284(5417): 1183 - 1187. [Abstract] [Full Text]

				H.-S. Jun, C.-S. Yoon, L. Zbytnuik, N. van Rooijen, and J.-W. Yoon The Role of Macrophages in T Cell-mediated Autoimmune Diabetes in Nonobese Diabetic Mice J. Exp. Med., January 18, 1999; 189(2): 347 - 358. [Abstract] [Full Text] [PDF]

				M. Peterson and A. J. Sant The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM J. Immunol., September 15, 1998; 161(6): 2961 - 2967. [Abstract] [Full Text] [PDF]

				L. S. Wicker Major Histocompatibility Complex-linked Control of Autoimmunity J. Exp. Med., October 6, 1997; 186(7): 973 - 975. [Full Text] [PDF]

				D. Schmidt, J. Verdaguer, N. Averill, and P. Santamaria A Mechanism for the Major Histocompatibility Complex-linked Resistance to Autoimmunity J. Exp. Med., October 6, 1997; 186(7): 1059 - 1075. [Abstract] [Full Text] [PDF]